Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The ...

Baptist Hospital's new cancer center in Southeast Texas offers advanced HyperArc radiation technology, drastically cutting ...

In a groundbreaking development, First Ascent Biomedical unveils a compelling narrative of resilience and innovation through ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and patient-centered outcomes. Pharmacy and precision medicine operations are crucial, ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

The National Cancer Institute, an agency of the National Institutes of Health, awarded Louisiana State University Health New Orleans and Tampa, Fla.-based Moffitt Cancer Center a joint $2 million ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors ...